Immutep Ltd Sponsored ADR IMMP 深 沪
交易中 03-26 09:52:12 美东时间
0.3523
-0.016
-4.27%
华盛通- 最 高0.3696
- 今 开0.3696
- 成交量 20.73万股
- 最 低 0.3523
- 昨 收 0.368
- 总市值 5191.92万
- 52周最高 3.5299
- 市盈率 静 --
- 换手率 0.14%
- 52周最低 0.3518
- 委 比 61.01%
- 总股本 1.47亿
- 历史最高 7.95
- 量 比 13.90
- 振 幅 4.70%
- 历史最低 0.3518
- 每 手 1
- 风险率 0.56%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Immutep Advances First-in-Class LAG-3 Agonist IMP761 With Positive Phase I Progress
Immutep ( ($IMMP) ) has issued an announcement. On March 19, 2026, Immutep repo...
03-20 18:29
美股大行评级 | 韦德布什升美光科技目标价升至500美元，维持"跑赢大市"评级
今日重点评级关注：Piper Sandler：维持Allogene疗法"超配"评级，目标价从7美元升至8美元；B. Riley证券：维持Oncology Institute"买入"评级，目标价从6美元升至8美元
03-16 18:19
盘前：纳指期货涨0.36% 油价维持在100美元上方
欧美股市周五小幅反弹，油价维持在100美元上方，市场对全球通胀飙升的担忧也随之加深。伊朗战争进入第二周之际，一项全球股票指数势将连续第二周下跌，此前该指数曾...
03-13 20:25
美股机会日报 | 特朗普：必要时将护航霍尔木兹海峡！威胁加大对伊朗打击；美联储最青睐通胀指标PCE物价指数将公布
特朗普：必要时将护航霍尔木兹海峡！威胁加大对伊朗打击；美联储最青睐通胀指标PCE物价指数将于20:30公布；Adobe盘前跌近8%，公司CEO掌舵18年后辞职>>
03-13 20:13
Citizens Downgrades Immutep to Market Perform
Citizens analyst Reni Benjamin downgrades Immutep (NASDAQ:IMMP) from Market Outperform to Market Perform.
03-13 18:34
Baird Downgrades Immutep to Neutral, Lowers Price Target to $1
Baird analyst Joel Beatty downgrades Immutep (NASDAQ:IMMP) from Outperform to Neutral and lowers the price target from $7 to $1.
03-13 18:25
Why Oncology Institute Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
The Oncology Institute (TOI) stock rose in pre-market trading after reporting better-than-expected financial results. Other gainers include ISPC, PAYP, and EONR.
03-13 17:41
TACTI-004 Phase III Study in First Line NSCLC to be discontinued following Futility Analysis
Immutep announced the Independent Data Monitoring Committee recommended halting the Phase III TACTI-004 trial of eftilagimod alfa in first-line non-small cell lung cancer due to a futility analysis. The trial enrolled 756 patients globally to evaluate efti combined with pembrolizumab and chemotherapy. Immutep expressed disappointment but will review data and extend its cash runway beyond Q2 2027.
03-13 12:00
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
